A bipartisan Senate continuing resolution released on August 2, 2026 would bar the White House Office of Management and Budget from finalizing or enforcing its contested rewrite of federal grantmaking rules until December 11, 2026 — pushing the fight past the October 1, 2026 date OMB had set for the rule to take effect. The provision, tucked into the stopgap funding bill that keeps the government open past the current deadline, is a rare instance of Senate Republicans joining Democrats to check a White House regulatory push on research funding. As of this writing the Senate has voted to advance the bill (cloture invoked 89-4) but final Senate passage, House action, and the President’s signature are still required before the block is binding law — research offices should treat this as a real but not yet final development.
What the Provision Actually Does
According to Roll Call’s reporting on the released text, the Senate CR would delay OMB from finalizing its “Regulation for Federal Financial Assistance” — the formal name of the proposed rewrite of 2 CFR Part 200, the Uniform Guidance that governs how federal grants are administered — and would prohibit OMB from issuing or finalizing any substantially similar rule before December 11, 2026. Forbes reported the same provision as language that would “prevent the White House Office of Management and Budget from implementing its ‘Regulation for Federal Financial Assistance’ on October 1 as originally planned,” with the December 11 date chosen to align with the CR’s own funding expiration, which has the practical effect of pushing the decision past the November 2026 midterm elections.
The provision does not repeal or withdraw the proposed rule. It pauses OMB’s ability to finalize it. If the CR passes with this language intact, the rulemaking itself remains open on OMB’s docket, and OMB regains the ability to finalize it once the CR expires on December 11, 2026, unless Congress acts again before then.
How the Rule Got Here: A Timeline
| Date | Event |
|---|---|
| August 7, 2025 | Executive Order 14332 directs agencies to revise discretionary grant terms, including termination-for-convenience rights and review of F&A cost treatment. See CASRAI’s EO 14332: What It Changes for Discretionary Grants. |
| May 29, 2026 | OMB publishes the proposed rule in the Federal Register under docket OMB-2026-0034, including the provision requiring senior political-appointee sign-off on discretionary awards before issuance and language recasting scientific peer-review recommendations as advisory rather than binding. See CASRAI’s OMB Grants Rule Would Give Political Appointees Final Sign-Off. |
| July 13, 2026 | The rule’s 45-day public comment period closes. Forbes reported more than 290,000 comments had been submitted by early August, the large majority in opposition, according to reporting cited in CASRAI’s companion piece on the OMB rewrite’s status. |
| August 2, 2026 | Senate Appropriations Chair Susan Collins (R-Maine) and Vice Chair Patty Murray (D-Wash.) release the text of a bipartisan continuing resolution funding the government through December 11, 2026, including the provision blocking the OMB rule. |
| August 3–4, 2026 | The Senate votes 89-4 to invoke cloture and proceed to the bill. Senior appropriator John Kennedy (R-La.) signals he may oppose final passage specifically over the grant-rule restriction; final Senate passage is expected before the August recess but had not been confirmed as of this writing. |
| December 11, 2026 | If enacted as written, this is when the CR — and its block on the OMB rule — expires. |
What Applies to Your Award Right Now
Research offices are already fielding questions about which rules govern a given award today. As of this writing, before the CR has been signed into law, nothing has actually changed in the regulatory text: the proposed rule is still just proposed. The table below separates what is currently in force from what the Senate provision would pause if enacted.
| Status | What it means for your award |
|---|---|
| Currently in force, unaffected by this CR provision | The existing 2 CFR Part 200 Uniform Guidance (as revised April 2024) still governs cost principles, audit requirements, and award administration. Standard agency peer-review and merit-review processes at NIH, NSF, and other grantmaking agencies continue to operate as they do today. |
| Still just a proposal, not yet in effect | OMB’s May 29, 2026 rewrite — including the political-appointee pre-issuance sign-off and the “peer review is advisory only” language — has not been finalized. It cannot lawfully take effect until OMB publishes a final rule, which normally follows notice-and-comment review of the record built during the comment period. |
| What the Senate provision would pause if the CR is enacted | OMB’s ability to finalize or enforce the proposed rule (or a substantially similar one) between enactment and December 11, 2026 — including the October 1, 2026 effective date OMB had targeted. |
| What the Senate provision does NOT do | It does not withdraw the proposed rule, close the docket, or prevent OMB from finalizing the rule after December 11, 2026 if the block is not renewed. |
Why a Continuing Resolution, Not a Standalone Bill
The block arrives as a rider on a funding bill rather than as freestanding legislation, which is why its fate is tied to the CR’s own path: it only becomes law if the CR itself passes the Senate, passes the House, and is signed, and it only stays in force for as long as that CR (or a successor funding bill carrying the same language) remains in effect. Roll Call reported that Collins described pushing for “significant changes to the proposed rule” during negotiations, while Murray criticized the omission of separate “pocket rescissions” language from the deal — a sign the grant-rule provision was one piece of a broader, actively negotiated appropriations package rather than a settled, freestanding policy outcome.
Why This Matters
Scientific societies and research-advocacy organizations spent the comment period arguing that the political-appointee sign-off and advisory-only peer-review language would shift effective control over which research grants get funded away from technical merit reviewers and toward political appointees at each agency — the subject of CASRAI’s earlier coverage of that specific provision. Congressional Republicans joining Democrats to at least temporarily check that specific piece of the rule, rather than the rulemaking as a whole, is unusual enough on its own to be the story: most of the CR’s other provisions reportedly reflect administration funding requests rather than pushback against them. Research administrators should treat the December 11 date as a real but explicitly temporary reprieve, not a resolution — the underlying rulemaking remains open, and its ultimate fate will depend on what Congress and OMB do as that date approaches.
Sources
- Roll Call, “Senate’s funding patch adds Trump requests but blocks grant rule,” August 2, 2026
- Forbes, “Senate Resolution Would Block New Trump OMB Rule Until December 11,” August 3, 2026
- The Hill, “Senate advances stopgap funding bill aimed at preventing government shutdown,” August 2026
- Federal Register, “Regulation for Federal Financial Assistance,” docket OMB-2026-0034
